COMP <GO>
MCK vs UNH // EV/EBITDA & P/E VALUATION
McKesson Corporation (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: MCK 6
— UNH 8
▲ EV/EBITDA & P/E VALUATION LEADER: UNH
LAST: $994.58 (+1.40%) • MKT CAP: $114.36B
valuation
19.5x
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
valuation
16.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MCK VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MCK | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 3.60% | 88.57% | -84.97 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 38.60% | 11.47% | +27.13 | MCK | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 19.5x | 16.4x | +3.05 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 5.00% | 6.48% | -1.48 | UNH | /fcf-yield <GO> |
| Operating Margin | 1.50% | 4.82% | -3.32 | UNH | /operating-margins <GO> |
| Net Profit Margin | 1.20% | 3.14% | -1.94 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 12.40% | 6.46% | +5.94 | MCK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.33% | 2.28% | -1.95 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.96 | 3.12 | +3.84 | MCK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 6.74% | -0.04 | MCK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 60.7 | 56.0 | +4.61 | MCK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.95 | 0.33 | +0.62 | MCK | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.2x | 17.1x | +3.11 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $114.36B | $364.66B | -$250.30B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MCK REV | UNH REV | MCK GROSS % | UNH GROSS % | MCK FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $403.43B | $447.57B | 3.6% | 88.7% | $5.72B | $16.07B |
| FY 2024 | $359.05B | $400.28B | 3.7% | 88.3% | $5.55B | $20.70B |
| FY 2023 | $308.95B | $371.62B | 44.0% | 89.6% | -$9.59B | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MCK // BETA 0.95
UNH // BETA 0.33